Patient Home
Welcome to Health Vidya. Discover trusted care and your own health — all in one place.
These highlights do not include all the information needed to use DESVENLAFAXINE EXTENDED-RELEASE TABLETS safely and effectively. See full prescribing information for DESVENLAFAXINE EXTENDED-RELEASE TABLETS. DESVENLAFAXINE extended-release tablets, for oral use Initial U.S. Approval: 2008
Medication labelWhy this: Advisory · dailymed-prescription
Desvenlafaxine is indicated for the treatment of adults with major depressive disorder (MDD) [see Clinical Studies (14)].
- generic_name
- desvenlafaxine succinate
- product_names
- Desvenlafaxine Succinate
- ndc
- 51991-006, 51991-311, 51991-312, 51991-311-14, 51991-311-33, 51991-311-90, 51991-311-01, 51991-311-10, 51991-311-11, 51991-311-80, 51991-312-14, 51991-312-33, 51991-312-90, 51991-312-01, 51991-312-10, 51991-312-11, 51991-312-80, 51991-006-33, 51991-006-90, 51991-006-01, 51991-006-10, 51991-006-11, 51991-006-80
- group
- drugs
- license
- us-gov-pd
- attribution
- Courtesy of the National Library of Medicine
- reviewed
- 2026-09-18
- language
- en